During the past decade, Memorial Sloan-Kettering Cancer Center; Hematology/Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan-Kettering Cancer Center; Hematology/Oncology" #1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan-Kettering Cancer Center; Hematology/Oncology" are "Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Lymphoma, Follicular" (1 trials). Many other conditions were trialed in "Memorial Sloan-Kettering Cancer Center; Hematology/Oncology" in a lesser frequency.

Most popular intervention types in "Memorial Sloan-Kettering Cancer Center; Hematology/Oncology" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab (MPDL3280A) [TECENTRIQ]" (1 trials), "Lenalidomide" (1 trials), "Letrozole" (1 trials), "Mosunetuzumab" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan-Kettering Cancer Center; Hematology/Oncology" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Memorial Sloan-Kettering Cancer Center; Hematology/Oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Memorial Sloan-Kettering Cancer Center; Hematology/Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan-Kettering Cancer Center; Hematology/Oncology, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".